Enhance Your Prediction of PKPD, Accurate Dosing Regime and Immuno-Modulation of LNP for Long-Term Patient Safety and Potency

Following the success of LNP-mRNA vaccines, we have seen an influx of novel types of lipids based nanocarriers over the last 12 months, progress has been made to minimize immuno-toxicity challenges – from maximizing therapeutic window to fine-tuning the immune response. 

The highly anticipated Lipid Nanoparticle Immunogenicity and Toxicity Summit takes place this December to unite 80+ senior leaders as the definitive meeting for clinical pharmacology, immunogenicity, bioanalytical development leaders to stay at the forefront, arming you with practical takeaways and lessons learned.

Across 3 days, we will delve into:

HW220702 LNP Immunogenicity and Toxicity logo Favicon

Immunomodulation strategies to increase the therapeutic window

HW220702 LNP Immunogenicity and Toxicity logo Favicon

Translatable preclinical models to revolutionize clinical relevancy 

HW220702 LNP Immunogenicity and Toxicity logo Favicon

Dosing considerations dependent on your disease indication, route of administration and patient group for improved safety

And much more!

Hear the latest insights and case studies to optimize your prediction of PKPD, accurate dosing regime and immuno-modulation of LNP for long-term patient safety and potency.

Across 3 days, with over 6 hours of networking, this is your must-attend summit in 2022, to join the likes of AstraZeneca, Bristol Myers Squibb, NanoVation Therapeutics, Vertex Pharmaceuticals to lay the foundation for robust immunotoxicity protocols, propelling your novel pipeline growth.

Time: 09:00 to 16:00

The COVID-19 pandemic disrupted healthcare and reinforced the need to improve physician and patient experiences, quality of care and financial outcomes. Connect with leading Healthcare experts on business-critical challenges and disruptive technology and drive your industry forward collaboratively. Connect with 70+ senior leaders for a curated agenda focused on tackling your current business critical challenges and driving industry forward. Our summits are designed to help you.

Read on gdsgroup.com

The GIANT (Global Innovation and New Technology) Health Event is Europe's leading, unmissable innovation festival with numerous informative conferences, 100s of world-class speakers, immersive workshops, and a cutting edge health tech startup competition for prizes. Our vision is to improve the health and well-being of people around the world, by facilitating healthcare innovation and supporting health-tech entrepreneurs and investors. Don't miss out. Join the largest, most valuable group of everyone involved in health and innovation. Our GIANT 2022 event is an invaluable, cost-effective global hybrid event. Combining both a real world physical trade show and multiple conferences in central London, as well as a sophisticated and engaging virtual event based on GIANT Health’s proprietary Virtual Event Platform. In 2022 GIANT Health is delivering new and improved services to exhibitors, sponsors, and strategic partners – more valuable than virtual or face-to-face only events.

Read on giant.health

Deciding to replace or purchase an eQMS has far-reaching consequences. The right choice can save a company’s quality department thousands of dollars and hours, making the team a hero, but a poor one can result in considerable user frustration and negative ROI. Register for this webinar and take an inside look at ORIC Pharmaceuticals’ brilliant eQMS decision matrix. See how they compared, selected, implemented, customized, validated and launched their eQMS quickly, with incredible results.

Attendees will gain insights into:

• How ORIC carefully weighed the pros and cons of several leading quality systems — and why the most popular one was far from their first choice
• Tips for getting the best price on eQMS, including pricing pitfalls to avoid
• Secrets for a smooth implementation with the least disruption in day-to-day routines
• Why out-of-the-box configurations rarely work, and how Intellect helped ORIC avoid wasted time, restructuring of processes and user frustrations

Read on xtalks.com

Since the 1980s, researchers have sought to develop surgical robotic technologies to augment or replace surgeons in complex and repetitive surgical procedures. These efforts have created a new industry, producing robots capable of improving human vision, repairing spinal injuries, performing minimally invasive hysterectomies, and more; all promising to improve consistency, reduce costs, and expand worldwide access to intricate surgical procedures. To accomplish these tasks, researchers and engineers needed to solve a variety of innovative mechanical and computing challenges in correlation to the complexity of the human body.

Attend this webinar and learn:

• A brief history of the development of surgical robots
• The vision and true benefits of robotic surgery
• The unique challenges in robotic surgery
• How machine learning can be applied in surgical robotics
• New avenues in research

Read on event.on24.com

Gain insights from Omnicell Specialty Pharmacy Services thought leaders and Bausch Health during an informative panel-style discussion to deliver proven best practices for optimizing specialty pharmacy to enhance patient outcomes.

In this session, ASHP Midyear attendees will learn how to:

• Navigate the complexities of getting specialty medications to patients in a timely manner
• Establish strong relationships with pharmaceutical manufacturers that improve access to Limited Distribution Drugs (LDDs) to better serve patient needs
• Best manage payer interactions to expedite specialty medication prior authorizations and approvals
• Optimize patient outcomes through improved medication adherence in specialty programs, reducing hospital readmissions

Read on go.omnicell.com

After the success of four global conferences, we are delighted to announce the 5th Global Webinar on Public Health, which will be held during December 06-07, 2022 as a live online event. Theme: World in Turmoil - Opportunities to Focus on the Public’s Health. We are delighted to welcome all the experts and delegates to join this two-day event which will provide an excellent opportunity to exchange information and strengthen the collaboration among Directors, Researchers, Professors, and Scholars from both academia and industry. This program provides two days of robust discussions on recent advancements and new strategies for current revolutions in public health. Our aim is to promote quality research and real-world impact in an atmosphere of true international cooperation between scientists and students by bringing together world-class researchers, International Communities, and research heads to discuss the latest developments and innovations in the fields of public health.

Read on globalscientificguild.com

Success of prostate cancer treatments has triggered a seismic shift in the status of the TRP field over the last year and sparked more research investment than ever before.

The Targeted Radiopharmaceuticals Summit Europe returns for its fourth year as the only event to address the needs of drug developers at all development stages, from both medical and operational perspectives.

Overcome the technical, logistical, and translational hurdles of radionuclide therapy development. This event will bring together clinical, logistical and manufacturing experts from radiopharma and academia to help you accelerate your development programmes, tackle supply chain issues and harness alpha- and beta- emitting radionuclides to take on new cancers.

Travel unrestricted to APLAR 2022 this year with the reopening of Hong Kong! We are excited to welcome you back with confidence to the first in-person APLAR Congress in 3 years! #APLAR22

APLAR 2022 Hong Kong Congress will share insights into the latest research and cutting-edge technologies. Our goal is to bring together a multi-disciplinary group of scientists, clinical practitioners, and allied health professionals from the region and worldwide to present and exchange breakthrough exciting ideas relating to Rheumatology.

There are so many reasons to attend:
- Reunite and network with the APLAR Rheumatology community as over 2,000 experts gather to exchange best practice
- Various workshops and courses covering GRAPPA, MRI Imaging and more
- 250+ expert presentations and specially curated industry symposia sessions
- Possibilities to attend virtually with on-demand access
- You key to the most important advances in Asia-Pacific for clinical rheumatology treatment

In the unlikely event that you test positive to covid-19 in Hong Kong, your medical expenses - including your isolation stay at a Government facility, RAT tests and any hospital stays - will be provided to you at no additional cost.

Can't join us in Hong Kong? APLAR 2022 will offer a virtual component, streaming the most anticipated sessions straight to your device!

We look forward to welcoming you to Hong Kong; with its iconic skyline, legendary kitchens, and lush, protected nature where rare birds and colourful traditions thrive.

Time: 7:00 am - 6:00 pm

While blockchain technology has only become synonymous with recent methods in financial assets management its applications are largely unlimited. But redistributing accountability for information into this new democracy poses new problems and practicalities, especially for the security conscious. At the most basic level, blockchain technology is composed of cryptographic algorithms. The creator of blockchain, Satoshi Nakamoto, developed a system in which the trust that we traditionally place in organizations to maintain trusted records (like banks) is transferred to the blockchain and cryptographic.

Read on blockchain.conferenceseries.com